| Authors: |
Wagstaff M; School of Life Sciences, University of Sussex, Brighton, UK., Sevim O; School of Life Sciences, University of Sussex, Brighton, UK., Goff A; School of Life Sciences, University of Sussex, Brighton, UK., Raynor M; Leeds Institute of Medical Research, Next Generation Sequencing Facility, University of Leeds, Leeds, UK., Park H; Brighton & Sussex Medical School, University of Sussex, Brighton, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Mancini EJ; School of Life Sciences, University of Sussex, Brighton, UK., Nguyen DTT; Centre for Haemato-oncology, Cancer Research UK Barts Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Chevassut T; Brighton & Sussex Medical School, University of Sussex, Brighton, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Blair A; Bristol Institute for Transfusion Sciences, NHS Blood & Transplant, Bristol, UK., Castellano L; School of Life Sciences, University of Sussex, Brighton, UK.; Department of Surgery and Cancer, Division of Cancer, Imperial Centre for Translational and Experimental Medicine (ICTEM), Imperial College London, London, UK., Newbury S; Brighton & Sussex Medical School, University of Sussex, Brighton, UK., Towler B; School of Life Sciences, University of Sussex, Brighton, UK., Morgan RG; School of Life Sciences, University of Sussex, Brighton, UK. rhys.morgan@sussex.ac.uk. |
